SCHEMBL15869752

SCHEMBL15869752

Cc1cc(OCc2ccccc2)c(O)c(OCc2ccccc2)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.56
TDP1 Q9NUW8 2/20 0.56
L3MBTL1 Q9Y468 2/20 0.56
MAPK1 P28482 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.53
CYP2C19 P33261 2/20 0.53
CYP2C9 P11712 1/20 0.53
LIPE Q05469 1/20 0.51
STAT3 P40763 1/20 0.49
HTT P42858 1/20 0.49
LMNA P02545 1/20 0.48
CYP1A2 P05177 1/20 0.48
PTGS1 P23219 1/20 0.48
SLC6A2 P23975 1/20 0.48
PTGS2 P35354 1/20 0.48
SLC6A3 Q01959 1/20 0.48
HIF1A Q16665 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
FFAR4 Q5NUL3 1/20 0.48
MAOB P27338 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15869751 0.91 MAPT (0.51) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL5940893 0.87 MAPT (0.47) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL14283740 0.86 CYP2C19 (0.53) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL5940931 0.86 L3MBTL1 (0.55) MAPTTDP1L3MBTL1SMN1; SMN2CYP2C19
SCHEMBL1186369 0.83 CYP1A2 (0.60) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL15869787 0.83 MAPT (0.58) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL1107092 0.82 MAPT (0.53) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL7436805 0.81 MAPT (0.56) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL11643569 0.80 MAPT (0.64) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2
SCHEMBL8419308 0.80 MAPT (0.59) MAPTTDP1L3MBTL1MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9366906-B2 Photoreactive compounds ROLIC AG (CH) 2016-06-14 US disclosed
US-20140192305-A1 PHOTOREACTIVE COMPOUNDS ROLIC AG (CH) 2014-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140192305-A1 PHOTOREACTIVE COMPOUNDS PCNA, CRY1, CRY2 MAPT 124/4885TDP1 1806/4885L3MBTL1 1772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.